BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 10969821)

  • 1. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?
    Caramori ML; Fioretto P; Mauer M
    Diabetes; 2000 Sep; 49(9):1399-408. PubMed ID: 10969821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of microalbuminuria in long-duration type 1 diabetes.
    Arun CS; Stoddart J; Mackin P; MacLeod JM; New JP; Marshall SM
    Diabetes Care; 2003 Jul; 26(7):2144-9. PubMed ID: 12832327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does microalbuminuria predict diabetic nephropathy?
    Tabaei BP; Al-Kassab AS; Ilag LL; Zawacki CM; Herman WH
    Diabetes Care; 2001 Sep; 24(9):1560-6. PubMed ID: 11522699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.
    Ellis D; Lloyd C; Becker DJ; Forrest KY; Orchard TJ
    Am J Kidney Dis; 1996 Jun; 27(6):809-18. PubMed ID: 8651245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
    Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
    Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history and clinical characteristics of CKD in type 1 and type 2 diabetes mellitus.
    Marshall SM
    Adv Chronic Kidney Dis; 2014 May; 21(3):267-72. PubMed ID: 24780454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes.
    Shigeta Y; Haneda M; Kikkawa R
    J Diabet Complications; 1991; 5(2-3):84-6. PubMed ID: 1770061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients.
    Halimi JM
    Diabetes Metab; 2012 Oct; 38(4):291-7. PubMed ID: 22622176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and associated features of albuminuria in Koreans with NIDDM.
    Lee KU; Park JY; Kim SW; Lee MH; Kim GS; Park SK; Park JS
    Diabetes Care; 1995 Jun; 18(6):793-9. PubMed ID: 7555505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.
    Gerstein HC; Bosch J; Pogue J; Taylor DW; Zinman B; Yusuf S
    Diabetes Care; 1996 Nov; 19(11):1225-8. PubMed ID: 8908384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcapillary escape rate of albumin in type II diabetic patients. The relationship with microalbuminuria and hypertension.
    Nannipieri M; Penno G; Rizzo L; Pucci L; Bandinelli S; Mattei P; Taddei S; Salvetti A; Navalesi R
    Diabetes Care; 1997 Jun; 20(6):1019-26. PubMed ID: 9167118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microalbuminuria and diabetic nephropathy. Detection and correlation with other degenerative complications].
    Thivolet C; Ayzac L; Simonet C; Rebattu B; Bernard P; Tourniaire J
    Presse Med; 1990 Jun; 19(23):1075-80. PubMed ID: 2141408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of the intrarenal arterial resistance index for the identification and prediction of diabetic nephropathy.
    Masulli M; Mancini M; Liuzzi R; Daniele S; Mainenti PP; Vergara E; Genovese S; Salvatore M; Vaccaro O
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):358-64. PubMed ID: 18805683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular changes in normo- and microalbuminuric patients with long-standing insulin-dependent diabetes mellitus.
    Fioretto P; Mauer M
    Adv Nephrol Necker Hosp; 1997; 26():247-63. PubMed ID: 8922136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.
    Drummond K; Mauer M;
    Diabetes; 2002 May; 51(5):1580-7. PubMed ID: 11978659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.